switched from semaglutide to tirzepatide and gained weight Rebound gain after stopping or is real, but it’s not because the body is “damaged”—it reflects how the body adapts after weight loss. When the medication is stopped, Tirzepatide vs. Semaglutide for Weight

Patients on GLP-1 medications are often also in perimenopause or menopause, a period when oestrogen withdrawal is simultaneously driving collagen loss, skin thinning, and altered fat distribution

What They Caution Against: IV injections

The reality is that B12 injections can assist in weight management, but they are not the solution to quick weight loss

UFE preserves the uterus and has a recovery of one to two weeks, making it a leading option for fibroid-related menstrual issues

Related Stories Endotrophin may reveal metabolic risks linked to changing body fat Medically tailored grocery deliveries improve blood sugar control among diabetes patients Diet helps people lose weight regardless of genetic obesity risk Tirzepatide is being studied in the Study of Tirzepatide in Pediatric Participants with Type 2 Diabetes (SURPASS-PEDS) trial for children and adolescents with type 2 diabetes and the SURPASS-2 trial for those with obesity or overweight and related comorbidities

In cases of acute or severe hyperkalaemia (6.5 mmol/L or with ECG changes), urgent management according to UK Kidney Association guidance is required, with immediate review of all medications and appropriate emergency treatment